Heterogeneity of immune cells in human atherosclerosis revealed by scRNA-Seq.
Jenifer VallejoClément CochainAlma ZerneckeKlaus LeyPublished in: Cardiovascular research (2022)
Immune cells in atherosclerosis include T, B, natural killer (NK) and NKT cells, macrophages, monocytes, dendritic cells (DCs), neutrophils, and mast cells. Advances in single-cell RNA sequencing (sRNA-Seq) have refined our understanding of immune cell subsets. Four recent studies have used scRNA-Seq of immune cells in human atherosclerotic lesions and peripheral blood mononuclear cells (PBMCs), some including cell surface phenotypes revealed by oligonucleotide-tagged antibodies, which confirmed known and identified new immune cell subsets and identified genes significantly up-regulated in PBMCs from HIV+ subjects with atherosclerosis compared to PBMCs from matched HIV+ subjects without atherosclerosis. The ability of scRNA-Seq to identify cell types is greatly augmented by adding cell surface phenotype using antibody sequencing. In this review, we summarize the latest data obtained by scRNA-Seq on plaques and human PBMCs in human subjects with atherosclerosis.
Keyphrases
- single cell
- rna seq
- endothelial cells
- cell surface
- genome wide
- dendritic cells
- high throughput
- cardiovascular disease
- induced pluripotent stem cells
- pluripotent stem cells
- antiretroviral therapy
- hepatitis c virus
- hiv positive
- hiv infected
- stem cells
- immune response
- induced apoptosis
- signaling pathway
- gene expression
- electronic health record
- oxidative stress
- cell therapy
- mesenchymal stem cells
- endoplasmic reticulum stress
- big data
- bone marrow